Page last updated: 2024-09-03

valdecoxib and Arthritis

valdecoxib has been researched along with Arthritis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ormrod, D; Wagstaff, AJ; Wellington, K	1
Topol, EJ	1
Okie, S	1
Tabrizchi, R	1
FitzGerald, GA	1
Gotta, AW	1

Reviews

2 review(s) available for valdecoxib and Arthritis

Article	Year
Valdecoxib. Drugs, 2002, Volume: 62, Issue:14 Topics: Arthritis; Clinical Trials as Topic; Dysmenorrhea; Female; Humans; Isoxazoles; Pain; Sulfonamides	2002
Valdecoxib (Pharmacia). Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2 Topics: Arthritis; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drugs, Investigational; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Sulfonamides; Treatment Outcome	2002

Article

Year

Valdecoxib.

Drugs, 2002, Volume: 62, Issue:14

Topics: Arthritis; Clinical Trials as Topic; Dysmenorrhea; Female; Humans; Isoxazoles; Pain; Sulfonamides

2002

Valdecoxib (Pharmacia).

Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2

Topics: Arthritis; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drugs, Investigational; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Sulfonamides; Treatment Outcome

2002

Other Studies

4 other study(ies) available for valdecoxib and Arthritis

Article	Year
Arthritis medicines and cardiovascular events--"house of coxibs". JAMA, 2005, Jan-19, Volume: 293, Issue:3 Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Drug Approval; Humans; Isoxazoles; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration	2005
Raising the safety bar--the FDA's coxib meeting. The New England journal of medicine, 2005, Mar-31, Volume: 352, Issue:13 Topics: Advertising; Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Drug Labeling; Humans; Isoxazoles; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Sulfonamides; Sulfones; United States; United States Food and Drug Administration	2005
Coxibs: can this class of drugs survive? Vascular health and risk management, 2005, Volume: 1, Issue:1 Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Etoricoxib; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Lactones; Patient Selection; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2005
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach. The American journal of cardiology, 2002, Mar-21, Volume: 89, Issue:6A Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones	2002